Skip to content
Atlas Research Compounds

Pinealon vs. Cortagen

Two short peptide bioregulators whose proposed tissue associations require careful separation from independently replicated target-level evidence.

Short peptide bioregulator

Pinealon

Proposed as a short peptide bioregulator; direct molecular targets and independent replication remain limited.

Evidence score1/5

Preclinical foundation

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Short peptide bioregulator

Cortagen

Proposed as a tissue-associated short peptide bioregulator; target-level evidence remains limited.

Evidence score1/5

Preclinical foundation

The score summarizes evidence maturity, not safety, effectiveness, or suitability for any use.

Open full profile →

Side-by-side research context

DimensionPinealonCortagen
Catalog identityPinealon is mapped to short peptide bioregulator research.Cortagen is mapped to short peptide bioregulator research.
Research categoryPinealon is primarily organized around aging, cognition, and bioregulator models.Cortagen is primarily organized around neural bioregulator models.
Interpretive boundaryUse the Pinealon profile and verified study pages before inferring mechanism or outcomes.Use the Cortagen profile and verified study pages before inferring mechanism or outcomes.

Combined literature starting points

Comparison pages organize differences; they do not establish superiority, equivalence, or individual suitability.

  1. 01

    Short peptide bioregulator literature index

    PubMed, U.S. National Library of Medicine · Database

    Open source
  2. 02

    Atlas internal research database

    Internal Research Database · 2026 · Database

    Open source